Importantly, deletions of ADAM6 have been reported to have prognostic implications in pediatric ALL, specifically the B-cell precursor (BCP) ALL subtype [20] and chronic lymphoblastic leukemia [28]. This evidence concerns the gene ADAM6 and acute lymphoblastic leukemia.